2.71
price up icon3.44%   0.09
after-market Dopo l'orario di chiusura: 2.72 0.01 +0.37%
loading
Precedente Chiudi:
$2.62
Aprire:
$2.61
Volume 24 ore:
1.48M
Relative Volume:
0.82
Capitalizzazione di mercato:
$390.17M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-3.0094
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
+7.97%
1M Prestazione:
+21.52%
6M Prestazione:
-51.78%
1 anno Prestazione:
-67.27%
Intervallo 1D:
Value
$2.60
$2.73
Intervallo di 1 settimana:
Value
$2.345
$2.73
Portata 52W:
Value
$1.665
$10.03

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
Nome
Maravai Lifesciences Holdings Inc
Name
Telefono
(858) 546-0004
Name
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
Dipendente
580
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-18
Name
Ultimi documenti SEC
Name
MRVI's Discussions on Twitter

Confronta MRVI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
2.71 377.22M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-26 Downgrade Robert W. Baird Outperform → Neutral
2024-12-19 Iniziato Guggenheim Neutral
2024-12-05 Downgrade Goldman Neutral → Sell
2024-11-14 Iniziato Wolfe Research Peer Perform
2024-11-08 Downgrade William Blair Outperform → Mkt Perform
2024-08-28 Iniziato Wells Fargo Overweight
2024-08-13 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-04-10 Iniziato Craig Hallum Buy
2023-12-12 Aggiornamento BofA Securities Neutral → Buy
2023-08-08 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2023-05-23 Downgrade Credit Suisse Outperform → Neutral
2023-05-09 Downgrade Goldman Buy → Neutral
2023-01-05 Downgrade UBS Buy → Neutral
2022-12-14 Iniziato Deutsche Bank Buy
2022-12-07 Iniziato RBC Capital Mkts Outperform
2022-11-03 Downgrade BofA Securities Buy → Neutral
2022-08-25 Iniziato Credit Suisse Outperform
2021-08-05 Ripresa Credit Suisse Outperform
2020-12-16 Iniziato KeyBanc Capital Markets Overweight
2020-12-15 Iniziato BofA Securities Buy
2020-12-15 Iniziato Credit Suisse Outperform
2020-12-15 Iniziato Goldman Buy
2020-12-15 Iniziato Jefferies Buy
2020-12-15 Iniziato Robert W. Baird Outperform
2020-12-15 Iniziato Stifel Buy
2020-12-15 Iniziato William Blair Outperform
2020-12-14 Iniziato UBS Buy
Mostra tutto

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

pulisher
Jul 24, 2025

Is Maravai LifeSciences Holdings Inc. stock overhyped or has real potentialRapid market gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What institutions are buying Maravai LifeSciences Holdings Inc. stock nowFree Trend-Following Techniques - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Maravai LifeSciences Holdings Inc. stock priceFree Stock Market Forecast Reports - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Maravai LifeSciences Holdings Inc. a good long term investmentFree Daily Trading Room Entry - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Maravai LifeSciences Holdings Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Maravai LifeSciences Holdings Inc. stockExceptional trading results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

16,587 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by Teacher Retirement System of Texas - Defense World

Jul 22, 2025
pulisher
Jul 18, 2025

Maravai LifeSciences appoints Deloitte as new auditor, replaces EY - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Maravai LifeSciences appoints Deloitte as new auditor, replaces EY By Investing.com - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Johnson Fistel, PLLP Continues Investigation Claims on Behalf of Quantum Computing Inc. (QUBT), AppLovin Corporation (APP), Skyworks Solutions, Inc. (SWKS), and Maravai LifeSciences Holdings, Inc. (MRVI) Long-Term Shareholders - GlobeNewswire

Jul 18, 2025
pulisher
Jul 15, 2025

Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention5x Profit Potential - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Maravai LifeSciences Holdings Inc. stock price move sharplyHigh Potential Safe Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Maravai LifeSciences Holdings Inc. stock performs during market volatilityProtected Capital Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jul 14, 2025
pulisher
Jul 13, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 13, 2025
pulisher
Jul 12, 2025

Here's Why Maravai LifeSciences Holdings (NASDAQ:MRVI) Can Afford Some Debt - 富途牛牛

Jul 12, 2025
pulisher
Jul 11, 2025

MARAVAI LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - PR Newswire

Jul 11, 2025
pulisher
Jul 11, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 10, 2025

Traders Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 09, 2025
pulisher
Jul 06, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 05, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Hold” by Brokerages - Defense World

Jul 05, 2025
pulisher
Jul 04, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire

Jul 04, 2025

Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):